[1]
2020. Evaluation of the Level of CXCL10 in Patients with Parainfluenza Virus Type III (HPIV3). Medico Legal Update. 20, 1 (Apr. 2020), 422–428. DOI:https://doi.org/10.37506/mlu.v20i1.395.